Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144911
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2005-09-01
Brief Title:
ADVAIR DISKUS Inhaler Fluticasone PropionateSalmeterol Versus SEREVENT DISKUS Inhaler Salmeterol For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations ADVAIR DISKUS Inhaler and SEREVENT DISKUS Inhaler Are Trademarks of the GSK Group of Companies
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
SCO40043
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None